YOU ARE HERE: LAT HomeCollectionsAntacids


April 20, 2009 | Joe Graedon and Teresa Graedon
I had severe leg pain for months. My doctor did blood work and found that my vitamin D level was 8. She prescribed me 50,000 IUs per week for 12 weeks, and now my leg pain is almost nonexistent. This is a common prescription dose for correcting a severe vitamin D deficiency. Many people have less than optimal levels of this vitamin. Lower than 20 nanograms per milliliter indicates deficiency. Some experts believe that optimal levels should be at least 30.
June 14, 2010 | Joe Graedon, Teresa Graedon, The People's Pharmacy
I have used Pycnogenol for almost two years for horrible hot flashes and night sweats. I started with 200 milligrams. It did stop the symptoms, but it felt like I was trying to restart an old engine. I dropped the dose to 150 mg and found that is a good dose for me. The flashes and sweats are minimal and tolerable. An unexpected and welcome side effect is that my asthma is so much better. I was on Symbicort, maximum dosage, and could not wean myself off. I realized my asthma was better after using the Pycnogenol for a short while, and I tried to taper down again.
August 30, 1994 | From Associated Press
Eastman Kodak Co. announced Monday that it has agreed to sell its remaining Sterling Winthrop business, including non-prescription remedies such as Bayer aspirin, to health care giant SmithKline Beecham for $2.925 billion in cash. The sale is among the latest in the consolidation of the health care industry, where companies are merging to gain products and cut costs as changes cut deeply into profits. In another deal announced Monday, Ivax Corp.
January 31, 2005 | Elena Conis
Native to Central and South America, the spicy fruits known as peppers were first transported from the New World to the Old after the journeys of Columbus. European explorers dubbed the fruits "peppers" because they served the same purpose as the black peppercorn (actually a berry) in Europe: flavoring food.
November 18, 2009 | Andrew Zajac
The Food and Drug Administration on Tuesday warned consumers not to take popular heartburn medications Nexium or Prilosec if they use Plavix, a widely prescribed blood thinner that guards against heart attack and stroke. The two heartburn formulations can reduce the protective blood-thinning effect of Plavix by nearly half, according to a study undertaken at the request of the FDA by the blood thinner's marketers, Sanofi-Aventis and Bristol-Myers Squibb. Nexium and Prilosec inhibit a liver enzyme that is involved in converting Plavix into active form.
August 30, 1988 | ALLAN PARACHINI, Times Staff Writer
Ulcer sufferers, and people with more garden variety heartburn and indigestion, may be able to look forward to two new and interrelated treatments. But both treatments--a possible new drug for ulcer sufferers and the proposed recasting of an established remedy as an over-the-counter antacid--have raised questions about effectiveness and acceptable balance between risk and benefit.
They sprayed malathion and tried matchmaking with sterile mates, but the little pests kept swarming back. Now they're going for the lipstick dye. Officials hope the kiss of death for the crop-destroying Mediterranean fruit fly will be "SureDye," a red and yellow dye blend used to make pink lipstick.
October 22, 1993 | JAMES MAIELLA JR.
Moorpark council members have decided to cut the size of the city's Senior Center Advisory Committee from seven members to five--and in the process forcing the board's two most combative, outspoken members to reapply for one open seat. "Apparently what they want is a bunch of yes men," said Gerry Goldstein, a frequent City Council critic who was appointed to the advisory board last year. "I think every town needs at least one curmudgeon."
January 28, 1991
Things have been tense enough lately to give anybody a sour stomach. But it may be of some comfort to know that at least one industry is benefiting from our indigestion: According to Packaged Facts Inc., a New York research firm, the antacid market grew 5% last year and is expected to grow another 50% by 1995, when sales will reach $1.1 billion.
April 12, 1989 | From Associated Press
SmithKline Beckman Corp. and Britain's Beecham Group PLC announced today that they have agreed to merge to form the world's second-largest drug maker. "For SmithKline, this merger marks the beginning of a promising new chapter for our employees, our shareholders and our customers," SmithKline Beckman Chairman Henry Wendt said at a news conference. "We will have one of the best and largest research and development organizations in the world, drawing on the scientific skills and traditions of the United States and Britain," Wendt said.
Los Angeles Times Articles